SANOFI
Sanofi India Limited
If management delivers what it guided
arithmetic on filed guidance and past valuations · not a price target
SANOFI
FY26 → FY27 · 1 year of guidance · ~0.7 years from today₹3,318 today
BEAR
₹2,542
-23%
5.8% a year · 53.9x exit
BASE
₹3,754
+13%
10% a year · 76.5x exit
BULL
₹5,246
+58%
13.6% a year · 103.5x exit
Where the market has priced it
40x74x today112x
management named no year; shown one year out
- the guided figure reached earnings through a low-confidence bridge
- multiple band rests on only 4 filed years
- this company's own median multiple sits 169% above its filed-industry peers; the scenario uses its own
How these numbers are produced
| Earnings base | FY26 fiscal year EPS ₹44.61 (screener) |
|---|---|
| Guided growth | 10% a year, said on the call of 05-Mar-2026 · transcript |
| Read across as | operating: unlabelled growth figure, read as revenue — low confidence |
| Delivery calibration | 0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings |
| Exit multiple | 53.87x / 76.51x / 103.53x, this company’s own p20 / median / p80 across 4 filed years |
| Filed-industry peers | median 28.43x across 38 peers — the cross-check, not the input |
| Arithmetic | base EPS × (1 + guided growth × delivery)1 × exit multiple |
Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.
What management said
from NSE earnings-call filings · extracted, not interpreted
generic growth 10%
Our plan is to how we can accelerate the double-digit growth for Soliqua moving forward both in private and in public sector and then also continue expanding Toujeo, which is also an innovator, which is U-300 glargine in the public sector.
Call 05-Mar-2026 · bridge confidence low · transcript PDF